◆英語タイトル:Laboratorio Reig Jofre SA (RJF) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8098
◆発行会社(調査会社):
GlobalData
◆発行日:2018年10月
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スペイン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
Laboratorio Reig Jofre SA (Reig Jofre) is a pharmaceutical company that researches, develops, manufactures and markets medicinal products and nutritional supplements. The company’s product categories include specialized technology products, specialty therapeutic areas, and consumer healthcare. Its specialized technology products include antibiotics, injectable, and freeze-dried products. Reig Jofre offers therapeutic products in the areas of dermatology, gynecology, and respiratory. It develops products in the dosage forms of oral and topical solutions, syrups, ointments, emulsions, micro-emulsions and creams, capsules, tablets, coated tablets and lozenges, among others. The company offers services such as research and development, regulatory services, manufacturing, and licensing of dossiers. The company caters to biotechnology and pharmaceutical companies. Reig Jofre is headquartered in Barcelona, Spain.
Laboratorio Reig Jofre SA (RJF) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Laboratorio Reig Jofre SA, Medical Devices Deals, 2012 to YTD 2018 9
Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Laboratorio Reig Jofre Acquires Right for Heparin Sodium in Spain from Chiesi Espana 11
Laboratorio Reig Jofre Acquires Product Licenses from Dema UK for USD5.4 Million 12
Partnerships 13
Laboratorio Reig Jofre and Leanbio Form Joint Venture 13
Reig Jofre Enters Into Co-Development Agreement With Ojer Pharma For Nobactine 14
Merger 15
Laboratorio Reig Jofre Merges with Natraceutical 15
Licensing Agreements 16
Laboratorio Reig Jofre Enters into Licensing Agreement with Church & Dwight 16
Acquisition 17
Laboratorio Reig Jofre Acquires Remaining 50% Stake in Geadic Biotec for USD2.5 Million 17
Laboratorio Reig Jofre SA – Key Competitors 18
Laboratorio Reig Jofre SA – Key Employees 19
Laboratorio Reig Jofre SA – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Joint Venture 21
Recent Developments 22
Financial Announcements 22
Jul 25, 2018: Reig Jofre increases sales by 7%, EBITDA by 12,5% and net profit by 7,5% at the end of june 22
Nov 14, 2017: Reig Jofre Reports Third Quarter 2017 Results 24
Aug 01, 2017: Reig Jofre: Results of First Half 2017 26
May 09, 2017: Reig Jofre: Results for the First Quarter of 2017 28
Corporate Communications 30
Oct 26, 2017: Reig Jofre: Appointments at the head of the corporate and financial management 30
Product News 31
Sep 13, 2017: Reig Jofre Continues to Strengthen its Leadership in ENT with the Launch Of Otospray, 3E Ear Hygiene 31
Mar 23, 2017: Reig Jofre Starts Marketing of a New Injectable Product Cefepime for Hospitals 32
Mar 23, 2017: Reig Jofre Starts Marketing of three New Injectable Products fror Hospitals 33
Other Significant Developments 34
Apr 09, 2018: Reig Jofre Will Invest In Technological Innovation To Triple Its Aseptic Productive Capacity Of Injectable And Lyophilized Products 34
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36
List of Tables
Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Laboratorio Reig Jofre SA, Deals By Therapy Area, 2012 to YTD 2018 8
Laboratorio Reig Jofre SA, Medical Devices Deals, 2012 to YTD 2018 9
Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Laboratorio Reig Jofre Acquires Right for Heparin Sodium in Spain from Chiesi Espana 11
Laboratorio Reig Jofre Acquires Product Licenses from Dema UK for USD5.4 Million 12
Laboratorio Reig Jofre and Leanbio Form Joint Venture 13
Reig Jofre Enters Into Co-Development Agreement With Ojer Pharma For Nobactine 14
Laboratorio Reig Jofre Merges with Natraceutical 15
Laboratorio Reig Jofre Enters into Licensing Agreement with Church & Dwight 16
Laboratorio Reig Jofre Acquires Remaining 50% Stake in Geadic Biotec for USD2.5 Million 17
Laboratorio Reig Jofre SA, Key Competitors 18
Laboratorio Reig Jofre SA, Key Employees 19
Laboratorio Reig Jofre SA, Other Locations 20
Laboratorio Reig Jofre SA, Subsidiaries 20
Laboratorio Reig Jofre SA, Joint Venture 21
List of Figures
Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Laboratorio Reig Jofre SA, Medical Devices Deals, 2012 to YTD 2018 9